Tag: corruption in research
We do not belong to the scientology movement, but this false accusation triggered an email correspondence that exposed the problematic happenings usually behind closed academic curtains.
The results of five large-scale clinical trials of antidepressants have never been made accessible to the public, a data set compiled by an international team of researchers shows. Their discovery highlights the incompleteness of available data on the safety and efficacy of antidepressant drugs.
The FDA recently approved lumateperone for schizophrenia. A review of the clinical trials reveals a testing process that is fatally flawed, and a new drug coming to market that doesn't provide a clinically meaningful benefit.
My story is not just about the personal costs of speaking truth to power. This is a story about institutional corruption and one of the worst show trials in academia that you can imagine. I have written a book that documents the truth, backed by leaked board room recordings, private emails and testimony from concerned citizens.
The field of psychiatry is awash with systematic reviews, meta-analyses and other published articles proclaiming various discoveries. But can this research be trusted? Let's examine one such article, "Suicide prevention strategies revisited: 10-year-old review," in which the author claims that the "anti-suicidal effects of clozapine and lithium have been substantiated."
Scientific freedom and integrity are constantly under attack, particularly in healthcare, which is dominated by the drug industry and other economic interests. To help preserve honesty and integrity in science, the new Institute for Scientific Freedom will open on March 9 with an international meeting in Copenhagen.
Contrary to popular belief, science is not immune to the corrupting influences of the society it operates in. When false results produced by p-hacked research have social, scientific, and political importance, and affect or harm the lives of millions of people while entire fields look on, it constitutes a scientific scandal.
Richard Smith, the chair of the board of trustees at BMJ, penned an editorial yesterday bringing increased scrutiny to research misconduct and medical fraud in the UK. Smith identifies denial about the seriousness of the problem and the reluctance of universities to submit themselves to reviews as the two major reasons that Britain has failed to address these issues.